Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;59(1):107-114.
doi: 10.2967/jnumed.116.178335. Epub 2017 Aug 17.

Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts

Affiliations

Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts

Daniel S Albrecht et al. J Nucl Med. 2018 Jan.

Abstract

The translocator protein (TSPO) is a commonly used imaging target to investigate neuroinflammation. Although TSPO imaging demonstrates great promise, its signal exhibits substantial interindividual variability, which needs to be accounted for to uncover group effects that are truly reflective of neuroimmune activation. Recent evidence suggests that relative metrics computed using pseudoreference approaches can minimize within-group variability and increase sensitivity to detect physiologically meaningful group differences. Here, we evaluated various ratio approaches for TSPO imaging and compared them with standard kinetic modeling techniques, analyzing 2 different disease cohorts. Patients with chronic low back pain (cLBP) or amyotrophic lateral sclerosis (ALS) and matching healthy controls received 11C-PBR28 PET scans. The occipital cortex, cerebellum and whole brain were first evaluated as candidate pseudoreference regions by testing for the absence of group differences in SUV and distribution volume (VT) estimated with an arterial input function. The SUV from target regions (cLBP study, thalamus; ALS study, precentral gyrus) was normalized with the SUV from candidate pseudoreference regions (i.e., occipital cortex, cerebellum, and whole brain) to obtain SUVRoccip, SUVRcereb, and SUVRWB The sensitivity to detect group differences in target regions was compared using various SUVR approaches, as well as distribution volume ratio (DVR) estimated with (blDVR) or without arterial input function (refDVR), and VT Additional voxelwise SUVR group analyses were performed. We observed no significant group differences in pseudoreference VT or SUV, excepting whole-brain VT, which was higher in cLBP patients than controls. Target VT elevations in patients (P = 0.028 and 0.051 in cLBP and ALS, respectively) were similarly detected by SUVRoccip and SUVRWB, and by refDVR and blDVR (less reliably by SUVRcereb). In voxelwise analyses, SUVRoccip, but not SUVRcereb, identified regional group differences initially observed with SUVRWB, and in additional areas suspected to be affected in the pathology examined. All ratio metrics were highly cross-correlated, but generally were not associated with VT. Although important caveats need to be considered when using relative metrics, ratio analyses appear to be similarly sensitive to detect pathology-related group differences in 11C-PBR28 signal as classic kinetic modeling techniques. The occipital cortex may be a suitable pseudoreference region, at least for the populations evaluated, pending further validation in larger cohorts.

Keywords: astrocytes; human; microglia; neuroimmunology; neuroinflammation.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Group comparison of SUV (left) and VT (right) from candidate pseudoreference regions evaluated in this work. Boxes represent 25%–75% interquartile range; horizontal line represents median. Diamonds represent subjects with the high-affinity TSPO genotype (Ala/Ala in the TSPO polymorphism); squares represent subjects with mixed-affinity genotype (Ala/Thr). CTRL = control.
FIGURE 2.
FIGURE 2.
Group comparison of 0- to 90-min time–activity curves for candidate pseudoreference regions. Each data point represents average within-group SUV for that time point ± SD. In cLBP plots (left), both patients matching same control subject are included. CTRL = control.
FIGURE 3.
FIGURE 3.
Group comparison of target VT estimates for cLBP (top) and ALS (bottom) groups. CTRL = control.
FIGURE 4.
FIGURE 4.
Group differences in target SUVR for each pseudoreference region. Horizontal bars represent group median. In cLBP plots (top), both patients matching same control subject are included as data points, but median value reflects only best matching patient included. CTRL = control.
FIGURE 5.
FIGURE 5.
ROC curves of target SUVR (dashed lines) and VT (solid line) for each pseudoreference region. Line of identity (chance, no discriminatory power) is shown in black.
FIGURE 6.
FIGURE 6.
Regions of elevated 11C-PBR28 SUVR in patients compared with controls. Results from SUVRWB analyses (analyses from original studies) are shown in green colorscale; SUVRoccip results are shown in red-yellow colorscale. (Top) cLBP > controls. (Bottom) ALS > controls. No regions were significant in either cLBP < controls or ALS < controls contrasts. aMCC = anterior midcingulate cortex; CTRL = control; dmPFC = dorsomedial prefrontal cortex; PCC = posterior cingulate cortex; SCA = subcallosal area; SMA = supplementary motor area; Thal = thalamus; vmPFC = ventromedial prefrontal cortex.
FIGURE 7.
FIGURE 7.
Group comparison of refDVRoccip and blDVRoccip. Horizontal bars represent group median. CTRL = control.

References

    1. Albrecht DS, Granziera C, Hooker JM, Loggia ML. In vivo imaging of human neuroinflammation. ACS Chem Neurosci. 2016;7:470–483. - PMC - PubMed
    1. Liu GJ, Middleton RJ, Hatty CR, et al. The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol. 2014;24:631–653. - PMC - PubMed
    1. Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118:1–17. - PMC - PubMed
    1. Lyoo CH, Ikawa M, Liow JS, et al. Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med. 2015;56:701–706. - PMC - PubMed
    1. Kreisl WC, Lyoo CH, McGwier M, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain. 2013;136:2228–2238. - PMC - PubMed

Publication types

Substances

LinkOut - more resources